Poison pill agreement CASES
A poison pill agreement is a defensive strategy used by a company to deter or make more expensive an unwanted takeover.
It typically allows existing shareholders (other than the hostile bidder) to acquire additional shares at a discount if a specified shareholding threshold is crossed, thereby diluting the bidder’s stake.
Definition and principles
A poison pill is not a literal contract but a mechanism embedded in a company’s constitutional documents or shareholder rights plan. It is designed to:
- Protect the board’s negotiating position
- Prevent coercive or opportunistic bids
- Encourage bidders to negotiate with directors
The effect is to make a takeover significantly more costly or impractical unless the bidder secures board approval.
In the UK, takeover regulation is governed by the Panel on Takeovers and Mergers under the City Code on Takeovers and Mergers. The Code restricts many defensive measures once a bid is imminent or underway.
Common forms
Flip-in plans: Existing shareholders (excluding the bidder) may buy additional shares at a discount once the bidder exceeds a specified percentage.
Flip-over plans: Shareholders gain rights exercisable after a merger, often to acquire shares in the acquiring company at favourable terms.
Issuance triggers: Rights are activated automatically upon the acquisition of a defined stake.
These mechanisms dilute the bidder’s voting power and economic interest.
Legal position in the UK
Unlike the United States, poison pills are rarely used in UK public companies. The Takeover Code includes a “no frustration” rule, limiting directors’ ability to take action that could frustrate a bid without shareholder approval.
As a result:
- Boards cannot unilaterally deploy many defensive tactics once an offer is in contemplation
- Shareholder approval is often required for significant defensive measures
- Poison pill arrangements are therefore more common in jurisdictions with greater board discretion.
Legal implications
If improperly implemented, a poison pill may:
- Breach directors’ duties to promote the success of the company.
- Conflict with takeover regulation.
- Be challenged as an improper use of powers.
Where permitted, however, such arrangements can enhance negotiating leverage and protect long-term shareholder value.
Practical importance
Poison pill mechanisms illustrate the tension between:
- Board autonomy
- Shareholder democrac
- Market efficiency in corporate control
Understanding their limits is essential for directors, shareholders and advisers involved in contested takeovers.
Home » Poison pill agreement
Criterion sought to invalidate a 'poison pill' agreement (SSA) signed by directors without proper authority. The House of Lords held the case turned on whether directors had actual or apparent authority to bind the company, not on 'knowing receipt' or unconscionability principles. The appeal was dismissed, requiring trial on authority...